From Arizona to Gretna, Nebraska: Changing Access to Affordable Weight Loss

From Arizona to Gretna, Nebraska: Changing Access to Affordable Weight Loss

Access to affordable, medically supervised weight loss is expanding—and ZYP Medical is leading the charge across states like Nebraska, Arizona, Iowa, South Dakota, Colorado, and Kansas. Using compounded GLP-1 medications and a telemedicine-first model, we’re making proven treatments available to more people than ever before.

What Are Compounded GLP-1s?

GLP-1 receptor agonists like semaglutide (used in brand names) have been shown to significantly reduce weight by controlling appetite and blood sugar. Compounded versions of these medications, when prepared by trusted pharmacies, provide a more accessible and affordable alternative—often with shorter wait times and lower cost.

A clinical study published by the Journal of the American Medical Association confirmed that GLP-1 medications led to an average of 15% body weight loss over 68 weeks in adults with obesity, compared to just 2.4% in the placebo group (Wilding et al., 2021). That’s a powerful difference—and one ZYP Medical makes it easier to access.

Making Weight Loss More Accessible—No Matter Where You Live

Traditional weight loss clinics are often limited to urban centers. But whether you’re in Gretna, NE or Glendale, AZ—ZYP Medical can support your weight loss journey.

Here’s how:

• Initial Consult: For all ZYP members, we begin with a tele-health visit to review your medical history and goals to make sure treatment is appropriate for you.
  
  
  
  

• Telemed Management for All States We Serve: After that, all follow-ups, dose adjustments, and coaching are done via secure telemedicine.
  
  
  
  

• Serving Surrounding States: We currently serve patients in Nebraska, Arizona, Iowa, South Dakota, Colorado, and Kansas—with more to come.
  
  
  
  

By removing the need for frequent in-office visits, we’re reducing both time and cost barriers to care.

Is It Affordable?

Yes—and that’s a huge part of why we do what we do. National chains can charge $900+ a month for GLP-1 medications. ZYP Medical offers compounded semaglutide starting at a fraction of that cost. Plus, our telemed model cuts out unnecessary overhead.

A 2023 study published in JAMA Internal Medicine highlighted that affordability and long-term accessibility are key to the sustainability of GLP-1 weight loss medications (Rubino et al., 2023). We couldn’t agree more.

The ZYP Medical Difference

We pair clinical oversight with a compassionate, personalized approach:

• Real providers who know you—not bots or pre-scripted chats
  
  
  

• Labs, prescriptions, and check-ins made easy via telehealth
  
  
  

• Continued monitoring to ensure safe, effective, and sustainable progress
  
  
  

Whether you're located in a small town in Kansas or a suburb of Omaha, ZYP Medical makes high-quality weight loss care available without compromise.

*This blog is for educational purposes only and should not serve or replace medical advice or recommendations from your healthcare provider.

References

Rubino, D., Abrahamsson, N., Davies, M., et al. (2023). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance. JAMA Internal Medicine, 183(1), 34–45. https://doi.org/10.1001/jamainternmed.2022.4530

Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183